Continuing Education - Pharmaceutical Representative
Saturday, Nov 21, 2009
Search

Continuing Education
Pharmaceutical Representative and The Certified Medical Representatives Institute Inc. have worked together since 1993 to provide continuing education to pharmaceutical sales representatives.

Available exclusively through Pharmaceutical Representative, continuing education articles and quizzes are free inside each issue of Pharmaceutical Representative. They can also be found online (please scroll down this page). Quizzes are processed for a $20 administration fee.

Sales reps who successfully pass the continuing education quizzes earn 0.25 CEU credits* and receive a certificate. Names of sales reps who pass four quizzes are published in Pharmaceutical Representative. Plus, the CMR Institute sends a letter of recognition to each successful sales rep's manager.

When representatives successfully complete four quizzes, they receive a certificate of achievement from the CMR Institute.

* The CMR/PR Continuing Education Program quizzes are not part of the CMR Institute's certification program and do not count as credits toward the CMR designation.

The current three-part series is:

Asthma
(October - December 2009)

Part 1: Overview of Asthma

Medical Ethics
(July - September 2009)

Part 1: Medical Ethics and the Pharmaceutical Industry
Part 2: Medical Ethics: Issues of Life and Death
Part 3: Medical Ethics: Economic Issues

Quiz: Medical Ethics

Contemporary Pharmacoeconomics
(April - June 2009)

Part 1: Pharmacoeconomics Overview
Part 2: Pharmacoeconomic Study Components
Part 3: Types of Pharmacoeconomic Analysis

Quiz: Contemporary Pharmacoeconomics

The Pharmaceutical Industry
(January, February and March 2009)

Part 1: Regulatory Basics
Part 2: Industry Basics: R&D and Marketing
Part 3: Industry Basics: Current Trends and Issues

Quiz: The Pharmaceutical Industry

Diabetes: Approaches in disease management
(October, November and December 2008)

Part 1 (.pdf file): Overview of diabetes
Part 2 (.pdf file): Diabetes management guidelines
Part 3 (.pdf file): Diabetes management programs

Quiz: Diabetes: Approaches in disease management

Disease Management
(July, August and September 2008)

Part 1 (.pdf file): Elements of disease management
Part 2 (.pdf file): Key issues in disease management
Part 3 (.pdf file): Disease management strategies

Quiz: Elements of disease management

Psychiatric Disorders and their Treatment
(April, May and June 2008)

Part 1 (.pdf file): Introduction to Psychotherapy
Part 2 (.pdf file): Pharmacology of Psychiatric Disorders
Part 3 (.pdf file): Selected Psychiatric Disorders

Quiz: Psychiatric disorders and their treatment

Evidence-Based Medicine
(January, February and March 2008)

Part 1 (.pdf file): Overview of Evidence-Based Medicine
Part 2 (.pdf file): Evidence-Based Medicine and Clinical Trials
Part 3 (.pdf file): EBM and Clinical Interactions

Quiz: Evidence-Based Medicine

Field Sales Management
(October, November and December 2007)

Part 1 (.pdf file): Building Teams
Part 2 (.pdf file): Optimizing the Team
Part 3 (.pdf file): Managing the District as a Business

Quiz: Field Sales Management

Focus on Women's Health
(July, August and September 2007)

Part 1 (.pdf file): Common Issues in Women's Health
Part 2 (.pdf file): Cardiovascular Disease and Cancer in Women
Part 3 (.pdf file): Female Response to Disease

Quiz: Focus on Women's Health

Focus on Pain Management
(April, May and June 2007)

Part 1 (.pdf file): Physiology of Pain
Part 2 (.pdf file): Options
Part 3 (.pdf file): Multidisciplinary Pain Management

Quiz: Focus on Pain Management

Long-Term Care
(January, February and March 2007)

Part 1 (.pdf file): Patient issues
Part 2 (.pdf file): Settings
Part 3 (.pdf file): Perspectives

Quiz: Long-Term Care

The Evolving Healthcare Community
(October, November and December 2006)

Part 1 (.pdf file): Overview of the healthcare system
Part 2 (.pdf file): Healthcare trends
Part 3 (.pdf file): Emerging strategies

Quiz: The Evolving Healthcare Community

Previous series:

Outcomes: Measurement, Management and Marketing
(July, August and September 2006)

Part 1 (.pdf file): Outcomes: Evolution and research
Part 2 (.pdf file): Outcomes: Studies and management
Part 3 (.pdf file): Outcomes: The representative's role

Quiz: Outcomes: Measurement, Management and Marketing

Pharmaceutical and Medical Research
(April, May and June 2006)

Part 1 (.pdf file): Overview of pharmaceutical research
Part 2 (.pdf file): Pharmaceutical research methodology
Part 3 (.pdf file): Pharmaceutical research costs

Quiz: Pharmaceutical and Medical Research

The Formulary Process
(January, February and March 2006)

Part 1 (.pdf file): The formulary system
Part 2 (.pdf file): Managing the pharmacy benefit
Part 3 (.pdf file): The representative and the formulary

Quiz: The Formulary Process

Business Ethics and the Pharmaceutical Industry
(October, November and December 2005)

Part 1 (.pdf file): The basics of business ethics
Part 2 (.pdf file): Ethics in research and healthcare access
Part 3 (.pdf file): Ethical business practices

Quiz: Business Ethics and the Pharmaceutical Industry

Pharmaceutical Marketing
(July, August and September 2005)

Part 1 (.pdf file): Marketing basics
Part 2 (.pdf file): Marketing: Approaches and regulations
Part 3 (.pdf file): New challenges in marketing

Quiz: Pharmaceutical Marketing

The 21st Century Physician
(April, May and June 2005)

Part 1 (.pdf file): Evolving practitioners in the 21st century
Part 2 (.pdf file): Changing roles of the 21st century physician
Part 3 (.pdf file): Emerging issues in the 21st century

Quiz: The 21st Century Physician

The Value of Pharmaceuticals
(January, February and March 2005)

Part 1: The value of pharmaceuticals
Part 2: Overview of pharmaceutical pricing
Part 3: Pharmaceutical affordability and value

Quiz: The Value of Pharmaceuticals

ADVERTISEMENT

Survey
The more people talk about healthcare reform the less consensus there is, what do you think of current efforts to reform the system?
Healthcare reform is
Good for pharma
Bad for pharma
Doomed to failure
An idea whose time has come
Good for pharma
18%
Bad for pharma
37%
Doomed to failure
24%
An idea whose time has come
21%
GOOGLE ADVERTISEMENTS
Click here